Bankhead R, Boullata J, Brantley S et al (2009) Enteral nutrition practice recommendations. JPEN J Parenter Enteral Nutr 33:122–167. https://doi.org/10.1177/0148607108330314
Boullata JI (2009) Drug administration through an enteral feeding tube. Am J Nurs 109:34-42; quiz 43. https://doi.org/10.1097/01.NAJ.0000361488.45094.28
Boullata JI (2021) Enteral Medication for the Tube-Fed Patient: Making This Route Safe and Effective. Nutr Clin Pract 36:111–132. https://doi.org/10.1002/ncp.10615
Williams NT (2008) Medication administration through enteral feeding tubes. Am J Health Syst Pharm 65:2347–2357. https://doi.org/10.2146/ajhp080155
Article CAS PubMed Google Scholar
Bischoff SC, Austin P, Boeykens K et al (2022) ESPEN practical guideline: Home enteral nutrition. Clin Nutr 41:468–488. https://doi.org/10.1016/j.clnu.2021.10.018
Joos E, Mehuys E, van Bocxlaer J et al (2015) Drug administration via enteral feeding tubes in residential care facilities for individuals with intellectual disability: an observational study. J Intellect Disabil Res 59:215–225. https://doi.org/10.1111/jir.12129
Article CAS PubMed Google Scholar
Bandy KS, Albrecht S, Parag B et al (2019) Practices Involved in the Enteral Delivery of Drugs. Curr Nutr Rep 8:356–362. https://doi.org/10.1007/s13668-019-00290-4
Article CAS PubMed Google Scholar
Hossaini Alhashemi S, Ghorbani R, Vazin A (2019) Improving knowledge, attitudes, and practice of nurses in medication administration through enteral feeding tubes by clinical pharmacists: a case-control study. Adv Med Educ Pract 10:493–500. https://doi.org/10.2147/AMEP.S203680
Article PubMed PubMed Central Google Scholar
Tillott H, Barrett D, Ruan J et al (2020) Survey of nurses' knowledge and practice regarding medication administration using enteral tubes. J Clin Nurs 29:4614–4622. https://doi.org/10.1111/jocn.15498
Dannhardt G (1993) Hagers Handbuch der Pharmazeutischen Praxis: Stoffe A-D, 5th edn. Springer, Berlin / Heidelberg, Berlin, Heidelberg
National Center for Biotechnology Information PubChem® PubChem®. https://pubchem.ncbi.nlm.nih.gov/. Accessed 04 Dec 2019
Gröning R (1987) Generika: Arzneistoffprofile und Bioverfügbarkeitsdaten von Fertigarzneimitteln. Dt. Apotheker-Verl, Stuttgart
DrugBank. https://go.drugbank.com/. Accessed 28 Dec 2020
Pharmacopoeia European (2022) European Pharmacopoeia, 11th Ed., English: 11.0 - 11.2: Subscription to Main volume + Supplement 1 + Supplement 2, 11. Auflage. Deutscher Apotheker Verlag, Stuttgart
Dressman JB, Nair A, Abrahamsson B et al (2012) Biowaiver monograph for immediate-release solid oral dosage forms: acetylsalicylic acid. J Pharm Sci 101:2653–2667. https://doi.org/10.1002/jps.23212
Article CAS PubMed Google Scholar
Lindenberg M, Kopp S, Dressman JB (2004) Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm 58:265–278. https://doi.org/10.1016/j.ejpb.2004.03.001
Bircher J, Sommer W (1999) Klinisch-pharmakologische Datensammlung, 2, völlig neu, bearb. Wiss. Verl.-Ges, Stuttgart
Reynolds JEF (ed) (1996) Martindale - The extra pharmacopoeia; [evaluated information on the world's drugs and medicines], 31st edn. Royal Pharmaceutical Soc, London
Truven Health Analytics Inc. (2016) DrugDex. https://www.micromedexsolutions.com. Accessed 18 Nov 2016
Handrock R, Herzig S (1998) Amlodipin (Amlodipine). Dtsch Med Wochenschr 123:19–20. https://doi.org/10.1055/s-0029-1233207
Article CAS PubMed Google Scholar
van Zwieten PA (1994) Amlodipine: an overview of its pharmacodynamic and pharmacokinetic properties. Clin Cardiol 17:III3-6
Williams HD, Ford L, Lim S et al (2018) Transformation of Biopharmaceutical Classification System Class I and III Drugs Into Ionic Liquids and Lipophilic Salts for Enhanced Developability Using Lipid Formulations. J Pharm Sci 107:203–216. https://doi.org/10.1016/j.xphs.2017.05.019
Article CAS PubMed Google Scholar
Meredith PA, Elliott HL (1992) Clinical pharmacokinetics of amlodipine. Clin Pharmacokinet 22:22–31. https://doi.org/10.2165/00003088-199222010-00003
Article CAS PubMed Google Scholar
Lv C, Wei C, Wang X et al (2014) The influence of food on the pharmacokinetics of amlodipine and losartan after single-dose of its compound tablets in healthy chinese subjects. Drug Res (Stuttg) 64:229–235. https://doi.org/10.1055/s-0033-1357143
Article CAS PubMed Google Scholar
Macwan JS, Fraczkiewicz G, Bertolino M et al (2021) Application of physiologically based biopharmaceutics modeling to understand the impact of dissolution differences on in vivo performance of immediate release products: The case of bisoprolol. CPT Pharmacometrics Syst Pharmacol 10:622–632. https://doi.org/10.1002/psp4.12634
Article CAS PubMed PubMed Central Google Scholar
Prichard BN (1987) Bisoprolol: a new beta-adrenoceptor blocking drug. Eur Heart J 8 Suppl M:121–129. https://doi.org/10.1093/eurheartj/8.suppl_m.121
Leopold G (1986) Balanced pharmacokinetics and metabolism of bisoprolol. J Cardiovasc Pharmacol 8(Suppl 11):S16-20. https://doi.org/10.1097/00005344-198511001-00003
Article CAS PubMed Google Scholar
A. Pfaff Pharmatrix. www.pharmatrix.de. Accessed 24 Jan 2017
Gleiter CH, Jägle C, Gresser U et al (2004) Candesartan. Cardiovasc Drug Rev 22:263–284. https://doi.org/10.1111/j.1527-3466.2004.tb00146.x
Article CAS PubMed Google Scholar
Figueroa-Campos A, Sánchez-Dengra B, Merino V et al. (2020) Candesartan cilexetil in vitro-in vivo correlation: predictive dissolution as a development tool. Pharmaceutics 12. https://doi.org/10.3390/pharmaceutics12070633
Gleiter CH, Mörike KE (2002) Clinical pharmacokinetics of candesartan. Clin Pharmacokinet 41:7–17. https://doi.org/10.2165/00003088-200241010-00002
Article CAS PubMed Google Scholar
Israili ZH (2000) Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension. J Hum Hypertens 14(Suppl 1):S73-86. https://doi.org/10.1038/sj.jhh.1000991
Article CAS PubMed Google Scholar
Jeon J-Y, Im Y-j, Kim Y et al (2013) Pharmacokinetic properties and bioequivalence of candesartan cilexetil in Korean healthy volunteers. Drug Dev Ind Pharm 39:1296–1299. https://doi.org/10.3109/03639045.2012.725732
Article CAS PubMed Google Scholar
Pyo Y-C, Nguyen TN, Lee Y-S et al (2023) Design of esomeprazole solid dispersion for improved dissolution and bioavailability using the supercritical anti-solvent technique. J Drug Deliv Sci Technol 88:104889. https://doi.org/10.1016/j.jddst.2023.104889
Vachhani R, Olds G, Velanovich V (2009) Esomeprazole: a proton pump inhibitor. Expert Rev Gastroenterol Hepatol 3:15–27. https://doi.org/10.1586/17474124.3.1.15
Article CAS PubMed Google Scholar
Heumann Pharma GmbH & Co. Generica KG (2023) Fachinformation esomeprazol heumann 20 mg/40 mg magensaftresistente tabletten. https://www.heumann.de/fileadmin/user_upload/produkte/infos/Fachinformation-Esomeprazol-Heumann-magensaftresistente-Tabletten.pdf. Accessed 03 Apr 2023
Hager H (1993) Hagers Handbuch der Pharmazeutischen Praxis: Band 8: Stoffe E-O, 5th ed. Springer Berlin / Heidelberg, Berlin, Heidelberg
Cvijić S, Parojčić J, Langguth P (2014) Viscosity-mediated negative food effect on oral absorption of poorly-permeable drugs with an absorption window in the proximal intestine: In vitro experimental simulation and computational verification. Eur J Pharm Sci 61:40–53. https://doi.org/10.1016/j.ejps.2014.04.008
Article CAS PubMed Google Scholar
Marasanapalle VP, Crison JR, Ma J et al (2009) Investigation of some factors contributing to negative food effects. Biopharm Drug Dispos 30:71–80. https://doi.org/10.1002/bdd.647
Article CAS PubMed Google Scholar
Kasim NA, Whitehouse M, Ramachandran C et al (2004) Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol Pharm 1:85–96. https://doi.org/10.1021/mp034006h
留言 (0)